Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Program: Scientific Session
General Topic: Clinical

Strength in Numbers: Using New Vaccines and Data to Protect the Immunocompromised

Sunday, October 26, 2025
9:00 AM – 10:00 AM Central Time

    Moderator(s)

  • AS

    Amit Saxena, MD, MSc

    NYU Grossman School of Medicine
    New York, New York, United States

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Terminated, August 10, 2024); Amgen: Advisor or Review Panel Member (Terminated, August 8, 2024); AstraZeneca: Advisor or Review Panel Member (Ongoing); Aurinia: Advisor or Review Panel Member (Terminated, January 8, 2025); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Terminated, December 3, 2024); Synthekine: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing)

  • AM

    Arielle Mendel, MD, FRCPC, MSc (she/her/hers)

    McGill University Health Centre
    Montréal, Quebec, Canada

    Disclosure information not submitted.

    • Session Coordinator(s)

  • CP

    Christopher Palma, MD

    University of Rochester
    Rochester, New York, United States

    Disclosure information not submitted.

Explore the latest strategies to optimize vaccine responses in immunocompromised patients, focusing on newly approved vaccines and evidence-based adjustments to immunosuppressive therapies. Experts will discuss how to balance disease management with immunogenicity, ensuring patients receive the maximum protective benefit. Additionally, the session will address the challenges posed by the re-emergence of previously controlled infections and how to adapt clinical practices accordingly. Attendees will gain practical insights to enhance patient care in this evolving landscape.

Learning Objectives:

  • Apply current vaccine guidelines for immunocompromised individuals
  • Evaluate the role of new vaccine products, and develop strategies for revaccination in the context of waning immunity due to aging and immunosuppressive therapies
  • Describe strategies for optimizing vaccine responses in individuals on immunosuppressive therapies

Presentations:

  • 9:00 AM – 9:30 AM Central Time
    Something New, Something Old, Something Borrowed: Optimizing Use of a Growing Portfolio of Vaccines

    Speaker: Olivia Kates, MD, MA – Johns Hopkins

  • 9:30 AM – 10:00 AM Central Time
    Modulating Immunomodulation: Strategie to Improve Vaccine Responses

    Speaker: Jin Kyun Park, MD (he/him/his) – Seoul National University College of Medicine